Deepak Rohila

Statistics

Publications

Citations

149

H-Index

Active since

2016

Affiliations

Translational Health Science and Technology Institute(Current)

University of California San Diego

International Centre for Genetic Engineering and Biotechnology

University of Turku

Deepak Rohila is an author at Translational Health Science and Technology Institute specializing in tumor-associated macrophage reprogramming, immunosuppressive microenvironment, and life sciences.

ORCID

Publications per year

2016–2023

Publications

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

Deepak Rohila, In Hwan Park, Timothy V. Pham et al. · Cancer Research · 2023 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Phosphatase PP2A is essential for T <sub>H</sub> 17 differentiation

Qin Xu, Xuexiao Jin, Mingzhu Zheng et al. · Proceedings of the National Academy of Sciences · 2018 · 42 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris

Neha Kaushik, Deepak Rohila, Upasana Arora et al. · BMC Biotechnology · 2016 · 25 citations · Full text

Life Sciences, Biotechnology, Infectious Diseases +17

Ultrasensitive and Robust Point-of-Care Immunoassay for the Detection of <i>Plasmodium falciparum</i> Malaria

Teppo Salminen, Farha Mehdi, Deepak Rohila et al. · Analytical Chemistry · 2020 · 21 citations · Full text

Veterinary Medicine, Infectious Diseases, Biosensors +16

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma

Deepak Rohila, In Hwan Park, Timothy V. Pham et al. · Frontiers in Immunology · 2023 · 18 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 5